SCHEMBL19631014

SCHEMBL19631014

Cc1cc(C)c(O)c(C(=O)Nc2nc3c(C(F)(F)F)cc(C(F)(F)F)cc3s2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.44
KDM4E B2RXH2 3/20 0.44
MAPT P10636 3/20 0.44
RORC P51449 1/20 0.44
NPC1 O15118 3/20 0.43
RAB9A P51151 1/20 0.43
NCS1 P62166 1/20 0.42
HPGD P15428 1/20 0.40
P2RX1 P51575 2/20 0.40
DYRK1A Q13627 2/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
LCK P06239 1/20 0.40
CSNK1D P48730 1/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19612096 0.90 NPC1 (0.45) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL19631017 0.86 MEN1 (0.51) ALDH1A1KDM4EMAPTRORCNPC1
SCHEMBL19627237 0.84 KDM4E (0.46) ALDH1A1KDM4EMAPTRORCNPC1
SCHEMBL19627273 0.82 NPC1 (0.52) ALDH1A1KDM4EMAPTRORCNPC1
SCHEMBL19631018 0.82 DYRK1A (0.63) NPC1RAB9ANCS1DYRK1ACSNK1D
SCHEMBL19612077 0.77 NCS1 (0.45) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL19612095 0.77 TMPRSS4 (0.57) P2RX1MEN1KMT2ATMPRSS4
SCHEMBL19612116 0.76 MEN1 (0.51) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL30810267 0.75 NCS1 (0.41) ALDH1A1KDM4EMAPTNPC1RAB9A
SCHEMBL27367503 0.75 NCS1 (0.41) ALDH1A1KDM4EMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458454-B1 2-HYDROXY-N-(BENZO[D]THIAZOL-2-YL)BENZAMIDE DERIVATIVES AS MITOCHONDRIAL UNCOUPLERS FOR THE TREATMENT OF METABOLIC DISEASES AND CANCER UNIV RUTGERS (US) 2021-11-24 EP disclosed
WO-2017201313-A1 NOVEL MITOCHONDRIAL UNCOUPLERS FOR TREATMENT OF METABOLIC DISEASES AND CANCER JIN SHENGKAN (US) 2017-11-23 WO disclosed